Published Online: Saturday, December 1, 2007

The Advisory Committee on Immunization Practices has recommended the flu vaccine FluMist for use in children aged 2 to 5. The recommendation follows an expanded approval of the vaccine?s use in September by the FDA.

The panel said the nasal influenza vaccine is an option and did not favor it over traditional flu shots. Children with a history of asthma or wheezing should get the flu shot, according to the committee members. The panel also voted for a government program that pays for vaccines to extend its FluMist coverage to the younger age group.

FluMist, made by MedImmune Inc, received FDA approval in 2003 for use in children ages 5 and older and in adults up to age 49.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues